| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.7 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |